Morristown, N.J. - Actavis Totowa LLC, a U.S. manufacturing division of the international generic pharmaceutical company Actavis Group, initiated a Class I nationwide recall of Digitek for oral use.
Morristown, N.J. - Actavis Totowa LLC, a U.S. manufacturing division of the international generic pharmaceutical company Actavis Group, initiated a Class I nationwide recall of Digitek (digoxin tablets, USP, all strengths) for oral use. Digitek is used to treat heart failure and abnormal heart rhythms.
The tablets are distributed by Mylan Pharmaceuticals Inc. under a Bertek label and by UDL Laboratories Inc. under a UDL label.
The voluntary recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. They may contain twice the approved level of the active ingredient than is appropriate, which could result in life-threatening adverse reactions in some animals. Details are available at www.activis.us.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More